• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BARD PERIPHERAL VASCULAR, INC. G2 FILTER SYSTEM - JUGULAR; VENA CAVA FILTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BARD PERIPHERAL VASCULAR, INC. G2 FILTER SYSTEM - JUGULAR; VENA CAVA FILTER Back to Search Results
Catalog Number RF320J
Device Problems Partial Blockage (1065); Migration or Expulsion of Device (1395); Difficult to Remove (1528); Malposition of Device (2616); Patient-Device Incompatibility (2682); Detachment of Device or Device Component (2907); Extrusion (2934); Migration (4003)
Patient Problems No Known Impact Or Consequence To Patient (2692); Thrombosis/Thrombus (4440)
Event Date 02/05/2012
Event Type  Injury  
Manufacturer Narrative
Manufacturing review: a manufacturing review was not performed as the lot number was not provided.Visual/microscopic inspection: as the device was not returned, an inspection could not be performed.Functional/performance evaluation: as the device was not returned, an evaluation could not be performed.Medical records review: as medical records were not provided, a review could not be performed.Image/photo review: no medical images have been made available to the manufacturer.Conclusion: the investigation is inconclusive for the reported failures.Based upon the available information, the definitive root cause is unknown.Labeling review: rnf: the current ifu (instructions for use) states: warnings/potential complications: possible complications include but are not limited to the following: filter fracture is a known complication of vena cava filters.Movement or migration of the filter is a known complication.This may be caused by placement in the ivc's with diameters exceeding the appropriate labeled dimensions specified in the ifu.Perforation of other acute or chronic damage of the ivc wall.The current ifu (instructions for use) states: warnings/potential complications: filter fractures are a known complication of vena cava filters.Movement, migration or tilt of the filter are known complications of vena cava filters.Perforation or other acute or chronic damage of the ivc wall.Filter tilt.Filter malposition.Note: it is possible that complications such as those described in the "warnings", "precautions", or "potential complications" sections of this instructions for use may affect the recoverability of the device and result in the clinician's decision to have the device remain permanently implanted.(b)(4).The information provided by bard represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bard.
 
Event Description
It was reported that approximately four years seven months post vena cava filter deployment, the patient allegedly experienced significant physical injuries as a result of the following events: the filter embedded, migrated, tilted, detached, perforated and/or otherwise became irretrievable.No additional information was provided.
 
Manufacturer Narrative
H10: as the lot number for the device was provided, a review of the device history records will be performed.The device has not been returned to the manufacturer for evaluation.The investigation of the reported event is currently underway.H11: b2,d1,d4,g1,h6(patient, device, method, result and conclusion).H11:section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Event Description
It was reported that approximately four years and seven months post vena cava filter deployment, the patient allegedly experienced significant physical injuries and the filter embedded, migrated, tilted, limb detached, perforated and/or otherwise became irretrievable.The current status of the patient is unknown.
 
Event Description
It was reported that approximately four years and seven months post vena cava filter deployment, the patient allegedly experienced significant physical injuries and the filter embedded, migrated, tilted, limb detached, perforated and/or otherwise became irretrievable.The current status of the patient is unknown.
 
Manufacturer Narrative
H10: manufacturing review: the device history records have been reviewed with special attention to the raw materials, subassemblies, manufacturing process, and quality control testing.This lot met all release criteria.There was nothing found to indicate there was a manufacturing related cause for this event.Investigation summary: the device was not returned for evaluation.Medical records were provided and reviewed.Approximately four years and seven months later, there is a thrombus extending from the left popliteal vein into the inferior vena cava filter.A venogram of left lower extremity was obtained.Little or no flow of blood was seen through the inferior vena cava.It has also revealed deep vein thrombosis from inside the inferior vena cava filter down through the left popliteal vein.Chronic thrombus was seen at the top of the inferior vena cava filter.Multiple aspirations of the thrombus through the top of the inferior vena cava filter were performed with 6~french envoy catheters as well as 5-french kumpe catheters to reduce the thrombus burden in inferior vena cava filter.Multiple attempts were made to retrieve the filter however, the filter would not move most likely secondary to tissue ingrowth.Flow remained poor through the filter despite significant efforts were taken to clear thrombus from above and below.Moderate residual filling defect was noted in the top of the filter most likely secondary to old thrombus or fibrotic tissue.The filter was unable to be removed secondary to tissue ingrowth.After one year and three months, a venogram was obtained demonstrating multiple areas of narrowing in the inferior vena cava, as well as the preexisting stents and at the location of previously placed inferior vena cava filter, which was approximately 3-4mm in diameter.A stent was placed in the common iliac vein at the point of narrowing underneath the aorta and a pamaz stent at the site of previously placed inferior vena cava filter and a self-expanding stent as stent placed already was unsatisfactory to push the filter to the side and maintain adequate lumen.A protege global positioning system stent was placed within the previously placed external iliac stent and up into his common iliac vein.At this point, a large sheath was then placed over the wire, past the inferior vena cava filter and a palmaz p5010 stent was loaded on to a balloon and deployed at the site of the filter.Therefore, the investigation is confirmed for the partial blockage and retrieval difficulties.However, the investigation is inconclusive for the alleged filter tilt, perforation of the inferior vena cava, filter migration and filter detachment.Additionally, it can be confirmed that the patient experienced thrombus above the filter post deployment.However, the relationship to the filter is unknown.Based on the available information, the definitive root cause is unknown.Labeling review: a review of product labeling documents (e.G.Procedural instructions, indications, warnings, precautions, cautions, possible complications, contraindications, and unit label) showed that the product labeling is adequate.H10: d4(expiry date: 03/2010), g3, h6(device, method).H11:section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
G2 FILTER SYSTEM - JUGULAR
Type of Device
VENA CAVA FILTER
Manufacturer (Section D)
BARD PERIPHERAL VASCULAR, INC.
1625 w 3rd st.
tempe AZ 85281
Manufacturer (Section G)
C.R. BARD, INC. (GFO)
289 bay road
queensbury NY 12804
Manufacturer Contact
judith ludwig
1415 w. 3rd street
tempe, AZ 85281
4803032689
MDR Report Key5816150
MDR Text Key50292131
Report Number2020394-2016-00714
Device Sequence Number1
Product Code DTK
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K052578
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer,Health Professional
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup,Followup
Report Date 12/18/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberRF320J
Device Lot NumberGFRC0770
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 06/29/2016
Initial Date FDA Received07/22/2016
Supplement Dates Manufacturer Received10/26/2021
12/15/2021
Supplement Dates FDA Received11/25/2021
12/18/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured03/23/2007
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age51 YR
Patient SexMale
-
-